According to Prometheus Biosciences's latest financial reports the company's total debt is $29.46 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2022-12-31 | $29.53 M | |
2020-12-31 | $7.39 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Epizyme EPZM | N/A | N/A | ๐บ๐ธ USA |
Akebia Therapeutics AKBA | $48.12 M | 63.33% | ๐บ๐ธ USA |
Agenus
AGEN | $78.01 M | 164.78% | ๐บ๐ธ USA |